SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-002768
Filing Date
2005-05-10
Accepted
2005-05-10 16:10:00
Documents
5
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b54783aie10vq.htm 10-Q 323469
2 EX-10.1 EMPLOYMENT AGREEMENT DATED JULY 26, 2004 b54783aiexv10w1.txt EX-10.1 44453
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b54783aiexv31w1.txt EX-31.1 3875
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b54783aiexv31w2.txt EX-31.2 3876
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO b54783aiexv32w1.txt EX-32.1 2238
  Complete submission text file 0000950135-05-002768.txt   379326
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 05816783
SIC: 2836 Biological Products, (No Diagnostic Substances)